Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

LETI Pharma S.L.U.

Spain Calle Del Sol 5, Zona Industrial Tres Cantos, 28760 Tres Cantos, Spain

About the sponsor

LETI Pharma S.L.U. focuses on subcutaneous immunotherapy for allergic rhinoconjunctivitis, with research centered on clinical responses to house dust mite and pollen allergens.

  • Dermatophagoides pteronyssinus and Dermatophagoides farinae
  • Grass pollen immunotherapy
  • Olive pollen immunotherapy

The sponsor’s trials examine treatment effects in patients with persistent nasal and ocular allergy symptoms, including those with controlled asthma.

About Specializations

LETI Pharma S.L.U. runs clinical trials in conditions such as Conjunctivitis allergic, Conjunctivitis, Mite allergy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Conjunctivitis allergic+1

Recruiting
Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.

Conjunctivitis allergic+1

Recruiting
Investigational
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.

Mite allergy

Not yet recruiting
Registered drug
Countries:PortugalPortugal
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:LETI Pharma S.L.U.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.